Developing an RNA Therapy for Rare Hereditary Nerve Disease @UniversityHospitals

Uploaded April 2026 | Updated September 2026, 1 week ago

Haiyan Zhou, MD, PhD, University College London, 2024 Oxford-Harrington Rare Disease Scholar, is advancing a targeted RNA therapy for hereditary sensory neuropathy, a rare and debilitating nerve disorder with no current treatment options, offering hope for patients and families. The Oxford-Harrington Rare Disease Centre is a transatlantic initiative dedicated to accelerating breakthrough treatments and cures for rare diseases. Learn more: OxfordHarrington.org.

Developing an RNA Therapy for Rare Hereditary Nerve Disease

Scrolling, Stress and the Teenage Brain: How EEG Biomarkers and Self-Management Can Change the Story

Ovarian Tissue Transplants Provide New Hope to Women with Ovarian Insufficiency

Alexander Wang, MD - Neurology, Movement Disorders

Leonidas Tapias, MD - Thoracic & Esophageal Surgery

$Haitham Sahawneh, MD - Ophthalmology Haitham Sahawneh, MD, is an ophthalmologist specializing in cornea disease and external refractive surgery at University Hospitals. To schedule an appointment with Dr. Sahawneh, visit: https://bit.ly/4vG7r1H$

University Hospitals Health Services Research Center Distinguished Speaker- Dilan Ellegala, MD

Graham Chapman, MD - Gynecologic Oncology

Sports Cardiology - UH Harrington Heart & Vascular

Applications of Artificial Intelligence in Medicine and Surgery: Promise and Peril